Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-48,000
Closed -$5.45M 111
2024
Q3
$5.45M Hold
48,000
0.24% 75
2024
Q2
$5.94M Buy
48,000
+20,500
+75% +$2.64M 0.27% 69
2024
Q1
$3.63M Buy
+27,500
New +$3.39M 0.17% 78
2023
Q3
Sell
-132,900
Closed -$15.3M 114
2023
Q2
$15.3M Buy
+132,900
New +$15.1M 0.84% 46

Other funds holding MRK

Covea Finance's MRK Position: Q4 2024 in Review

Covea Finance sold out of Merck (MRK) in Q4 2024, closing a stake of 48,000 shares — an estimated $5.45M sold.

Covea Finance first reported a position in MRK in Q2 2023 and held it in 4 quarters. The position peaked at $15.3M in Q2 2023. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • Covea Finance reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
  • Covea Finance sold 48,000 Merck shares in Q4 2024, an estimated $5.45M.
  • Covea Finance first reported a position in Merck in Q2 2023 and held it in 4 quarters.
  • Covea Finance's Merck position peaked at $15.3M in Q2 2023.
  • 3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on Covea Finance's 13F filing for Q4 2024, filed 14 Jan 2025.